Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Richman

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Muscle & Nerve|December 28, 2017
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myastheniaDonald B Sanders, Vern C Juel, Yadollah Harati, et al.
Nature Biotechnology|January 19, 2023
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.
Journal of Neuroimmunology|October 14, 2022
Enrichment of serum IgG4 in MuSK myasthenia gravis patientsDana L E Vergoossen, Annabel M Ruiter, Kevin R Keene, et al.
Neurology|December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG StudyRichard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.
BMJ Open|September 19, 2020
Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North AmericaJoshua D Green, Richard J Barohn, Emanuela Bartoccion, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Muscle & Nerve|December 28, 2017
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myastheniaDonald B Sanders, Vern C Juel, Yadollah Harati, et al.
Nature Biotechnology|January 19, 2023
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.
Journal of Neuroimmunology|October 14, 2022
Enrichment of serum IgG4 in MuSK myasthenia gravis patientsDana L E Vergoossen, Annabel M Ruiter, Kevin R Keene, et al.
Neurology|December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG StudyRichard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.
BMJ Open|September 19, 2020
Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North AmericaJoshua D Green, Richard J Barohn, Emanuela Bartoccion, et al.
Pageof 3